[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

China Parkinsons Disease Drug Market Research Report 2016

October 2016 | 122 pages | ID: CB5BC47C2A6EN
QYResearch

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Parkinsons Disease Drug

Revenue, means the sales value of Parkinsons Disease Drug

This report studies Parkinsons Disease Drug in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
  • GSK
  • Novartis
  • Boehringer Ingelheim
  • Teva Pharmaceutical
  • Abbvie
  • Merck
  • Akorn
  • Astellas Pharma
  • Desitin Arzneimittel
  • Endo Pharmaceuticals
  • F.Hoffmann-La Roche
  • H.Lundbeck
  • Kyowa Hakko Kirin Pharma
  • Orion
  • Stada Arzneimittel
  • Valeant
  • Apokyn
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by Application, this report focuses on consumption, market share and growth rate of Parkinsons Disease Drug in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
China Parkinsons Disease Drug Market Research Report 2016

1 PARKINSONS DISEASE DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Parkinsons Disease Drug
1.2 Parkinsons Disease Drug Segment by Type
  1.2.1 China Production Market Share of Parkinsons Disease Drug Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Applications of Parkinsons Disease Drug
  1.3.1 Parkinsons Disease Drug Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 China Market Size (Value) of Parkinsons Disease Drug (2011-2021)
1.5 China Parkinsons Disease DrugStatus and Outlook
1.6 Government Policies

2 CHINA PARKINSONS DISEASE DRUG MARKET COMPETITION BY MANUFACTURERS

2.1 China Parkinsons Disease Drug Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Parkinsons Disease Drug Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Parkinsons Disease Drug Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Parkinsons Disease Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Parkinsons Disease Drug Market Competitive Situation and Trends
  2.5.1 Parkinsons Disease Drug Market Concentration Rate
  2.5.2 Parkinsons Disease Drug Market Share of Top 3 and Top 5 Manufacturers

3 CHINA PARKINSONS DISEASE DRUG MANUFACTURERS PROFILES/ANALYSIS

3.1 GSK
  3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.1.2 Parkinsons Disease Drug Product Type, Application and Specification
    3.1.2.1 Type I
    3.1.2.2 Type II
  3.1.3 GSK Parkinsons Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.1.4 Main Business/Business Overview
3.2 Novartis
  3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.2.2 122 Product Type, Application and Specification
    3.2.2.1 Type I
    3.2.2.2 Type II
  3.2.3 Novartis 122 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.2.4 Main Business/Business Overview
3.3 Boehringer Ingelheim
  3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.3.2 129 Product Type, Application and Specification
    3.3.2.1 Type I
    3.3.2.2 Type II
  3.3.3 Boehringer Ingelheim 129 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.3.4 Main Business/Business Overview
3.4 Teva Pharmaceutical
  3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.4.2 Sept Product Type, Application and Specification
    3.4.2.1 Type I
    3.4.2.2 Type II
  3.4.3 Teva Pharmaceutical Sept Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.4.4 Main Business/Business Overview
3.5 Abbvie
  3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.5.2 Product Type, Application and Specification
    3.5.2.1 Type I
    3.5.2.2 Type II
  3.5.3 Abbvie Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.5.4 Main Business/Business Overview
3.6 Merck
  3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.6.2 Million USD Product Type, Application and Specification
    3.6.2.1 Type I
    3.6.2.2 Type II
  3.6.3 Merck Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.6.4 Main Business/Business Overview
3.7 Akorn
  3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.7.2 Pharma & Healthcare Product Type, Application and Specification
    3.7.2.1 Type I
    3.7.2.2 Type II
  3.7.3 Akorn Pharma & Healthcare Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.7.4 Main Business/Business Overview
3.8 Astellas Pharma
  3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.8.2 Product Type, Application and Specification
    3.8.2.1 Type I
    3.8.2.2 Type II
  3.8.3 Astellas Pharma Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.8.4 Main Business/Business Overview
3.9 Desitin Arzneimittel
  3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.9.2 Product Type, Application and Specification
    3.9.2.1 Type I
    3.9.2.2 Type II
  3.9.3 Desitin Arzneimittel Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.9.4 Main Business/Business Overview
3.10 Endo Pharmaceuticals
  3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.10.2 Product Type, Application and Specification
    3.10.2.1 Type I
    3.10.2.2 Type II
  3.10.3 Endo Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.10.4 Main Business/Business Overview
3.11 F.Hoffmann-La Roche
3.12 H.Lundbeck
3.13 Kyowa Hakko Kirin Pharma
3.14 Orion
3.15 Stada Arzneimittel
3.16 Valeant
3.17 Apokyn

4 CHINA PARKINSONS DISEASE DRUG CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2011-2016)

4.1 China Parkinsons Disease Drug Capacity, Production and Growth (2011-2016)
4.2 China Parkinsons Disease Drug Revenue and Growth (2011-2016)
4.3 China Parkinsons Disease Drug Production, Consumption, Export and Import (2011-2016)

5 CHINA PARKINSONS DISEASE DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Parkinsons Disease Drug Production and Market Share by Type (2011-2016)
5.2 China Parkinsons Disease Drug Revenue and Market Share by Type (2011-2016)
5.3 China Parkinsons Disease Drug Price by Type (2011-2016)
5.4 China Parkinsons Disease Drug Production Growth by Type (2011-2016)

6 CHINA PARKINSONS DISEASE DRUG MARKET ANALYSIS BY APPLICATION

6.1 China Parkinsons Disease Drug Consumption and Market Share by Application (2011-2016)
6.2 China Parkinsons Disease Drug Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Application
  6.3.2 Emerging Markets/Countries

7 PARKINSONS DISEASE DRUG MANUFACTURING COST ANALYSIS

7.1 Parkinsons Disease Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Parkinsons Disease Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Parkinsons Disease Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Parkinsons Disease Drug Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA PARKINSONS DISEASE DRUG MARKET FORECAST (2016-2021)

11.1 China Parkinsons Disease Drug Capacity, Production, Revenue Forecast (2016-2021)
11.2 China Parkinsons Disease Drug Production, Import, Export and Consumption Forecast (2016-2021)
11.3 China Parkinsons Disease Drug Production Forecast by Type (2016-2021)
11.4 China Parkinsons Disease Drug Consumption Forecast by Application (2016-2021)
11.5 Parkinsons Disease Drug Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Parkinsons Disease Drug
Figure China Production Market Share of Parkinsons Disease Drug by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Parkinsons Disease Drug Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure China Parkinsons Disease Drug Revenue (Million USD) and Growth Rate (2011-2021)
Table China Parkinsons Disease Drug Capacity of Key Manufacturers (2015 and 2016)
Table China Parkinsons Disease Drug Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Parkinsons Disease Drug Capacity of Key Manufacturers in 2015
Figure China Parkinsons Disease Drug Capacity of Key Manufacturers in 2016
Table China Parkinsons Disease Drug Production of Key Manufacturers (2015 and 2016)
Table China Parkinsons Disease Drug Production Share by Manufacturers (2015 and 2016)
Figure 2015 Parkinsons Disease Drug Production Share by Manufacturers
Figure 2016 Parkinsons Disease Drug Production Share by Manufacturers
Table China Parkinsons Disease Drug Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Parkinsons Disease Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Parkinsons Disease Drug Revenue Share by Manufacturers
Table 2016 China Parkinsons Disease Drug Revenue Share by Manufacturers
Table China Market Parkinsons Disease Drug Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Parkinsons Disease Drug Average Price of Key Manufacturers in 2015
Table Manufacturers Parkinsons Disease Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Parkinsons Disease Drug Product Type
Figure Parkinsons Disease Drug Market Share of Top 3 Manufacturers
Figure Parkinsons Disease Drug Market Share of Top 5 Manufacturers
Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GSK Parkinsons Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure GSK Parkinsons Disease Drug Market Share (2011-2016)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Parkinsons Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Parkinsons Disease Drug Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Parkinsons Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim Parkinsons Disease Drug Market Share (2011-2016)
Table Teva Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharmaceutical Parkinsons Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Teva Pharmaceutical Parkinsons Disease Drug Market Share (2011-2016)
Table Abbvie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbvie Parkinsons Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Abbvie Parkinsons Disease Drug Market Share (2011-2016)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Parkinsons Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Parkinsons Disease Drug Market Share (2011-2016)
Table Akorn Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Akorn Parkinsons Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Akorn Parkinsons Disease Drug Market Share (2011-2016)
Table Astellas Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Pharma Parkinsons Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Astellas Pharma Parkinsons Disease Drug Market Share (2011-2016)
Table Desitin Arzneimittel Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Desitin Arzneimittel Parkinsons Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Desitin Arzneimittel Parkinsons Disease Drug Market Share (2011-2016)
Table Endo Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Endo Pharmaceuticals Parkinsons Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Endo Pharmaceuticals Parkinsons Disease Drug Market Share (2011-2016)
Table F.Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table F.Hoffmann-La Roche Parkinsons Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure F.Hoffmann-La Roche Parkinsons Disease Drug Market Share (2011-2016)
Table H.Lundbeck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table H.Lundbeck Parkinsons Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure H.Lundbeck Parkinsons Disease Drug Market Share (2011-2016)
Table Kyowa Hakko Kirin Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kyowa Hakko Kirin Pharma Parkinsons Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Kyowa Hakko Kirin Pharma Parkinsons Disease Drug Market Share (2011-2016)
Table Orion Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Orion Parkinsons Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Orion Parkinsons Disease Drug Market Share (2011-2016)
Table Stada Arzneimittel Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Stada Arzneimittel Parkinsons Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Stada Arzneimittel Parkinsons Disease Drug Market Share (2011-2016)
Table Valeant Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Valeant Parkinsons Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Valeant Parkinsons Disease Drug Market Share (2011-2016)
Table Apokyn Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Apokyn Parkinsons Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Apokyn Parkinsons Disease Drug Market Share (2011-2016)
Figure China Parkinsons Disease Drug Capacity, Production and Growth (2011-2016)
Figure China Parkinsons Disease Drug Revenue (Million USD) and Growth (2011-2016)
Table China Parkinsons Disease Drug Production, Consumption, Export and Import (2011-2016)
Table China Parkinsons Disease Drug Production by Type (2011-2016)
Table China Parkinsons Disease Drug Production Share by Type (2011-2016)
Figure Production Market Share of Parkinsons Disease Drug by Type (2011-2016)
Figure 2015 Production Market Share of Parkinsons Disease Drug by Type
Table China Parkinsons Disease Drug Revenue by Type (2011-2016)
Table China Parkinsons Disease Drug Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Parkinsons Disease Drug by Type (2011-2016)
Figure 2015 Revenue Market Share of Parkinsons Disease Drug by Type
Table China Parkinsons Disease Drug Price by Type (2011-2016)
Figure China Parkinsons Disease Drug Production Growth by Type (2011-2016)
Table China Parkinsons Disease Drug Consumption by Application (2011-2016)
Table China Parkinsons Disease Drug Consumption Market Share by Application (2011-2016)
Figure China Parkinsons Disease Drug Consumption Market Share by Application in 2015
Table China Parkinsons Disease Drug Consumption Growth Rate by Application (2011-2016)
Figure China Parkinsons Disease Drug Consumption Growth Rate by Application (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Parkinsons Disease Drug
Figure Manufacturing Process Analysis of Parkinsons Disease Drug
Figure Parkinsons Disease Drug Industrial Chain Analysis
Table Raw Materials Sources of Parkinsons Disease Drug Major Manufacturers in 2015
Table Major Buyers of Parkinsons Disease Drug
Table Distributors/Traders List
Figure China Parkinsons Disease Drug Capacity, Production and Growth Rate Forecast (2016-2021)
Figure China Parkinsons Disease Drug Revenue and Growth Rate Forecast (2016-2021)
Table China Parkinsons Disease Drug Production, Import, Export and Consumption Forecast (2016-2021)
Table China Parkinsons Disease Drug Production Forecast by Type (2016-2021)
Table China Parkinsons Disease Drug Consumption Forecast by Application (2016-2021)


More Publications